Multiple sclerosis drug, Ocrevus, gets FDA approval – Washington Post
Fortune |
Multiple sclerosis drug, Ocrevus, gets FDA approval
Washington Post U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed … FDA approves first treatment for severe type of multiple sclerosis Excitement to Cautious Optimism — Reactions to Approval of Ocrevus With FDA Approval, Genentech Drug Becomes First For Severe MS Cases |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.